BeOne Medicines (ONC) Tax Provisions (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Tax Provisions data on file, last reported at $31.9 million in Q1 2026.

• Quarterly Tax Provisions rose 62.29% year-over-year to $31.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.1 million (up 14.92% YoY) and the FY2025 annual result came in at $129.9 million, up 16.22% from the prior year.
• Tax Provisions slipped to $31.9 million in Q1 2026 per ONC's latest filing, from $82.7 million in the prior quarter.
• Across five years, Tax Provisions topped out at $82.7 million in Q4 2025 and bottomed at $5.2 million in Q2 2025.
• The 5-year median for Tax Provisions is $14.4 million (2022), against an average of $21.9 million.
• The widest annual swing landed in 2022, when Tax Provisions surged 3639.57%; it then slumped 63.9% in 2025.
• Tracing ONC's Tax Provisions over 5 years: stood at $14.4 million in 2022, then advanced by 16.78% to $16.8 million in 2023, then surged by 296.46% to $66.5 million in 2024, then advanced by 24.36% to $82.7 million in 2025, then tumbled by 61.5% to $31.9 million in 2026.
• Per Business Quant, the three latest ONC Tax Provisions figures stand at $31.9 million (Q1 2026), $82.7 million (Q4 2025), and $22.3 million (Q3 2025).

Peer Comparison